Stock 0REN EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Edwards Lifesciences Corporation London S.E.

Equities

0REN

US28176E1082

Market Closed - London S.E.
Other stock markets
 14:34:46 05/02/2021 GMT 		5-day change 1st Jan Change
77.56 CHF +5.72% Intraday chart for Edwards Lifesciences Corporation -.--% -.--%
06-20 Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing MT
06-17 Edwards Lifesciences Corporation Announces Executive Changes CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
BU
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
PR
Edwards Lifesciences to Sell Critical Care to BD
BU
Edwards Lifesciences : Charter of the Audit Committee
PU
Edwards Lifesciences : First Quarter 2024 Fact Sheet
PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
BU
Edwards Lifesciences: Q1 Earnings Snapshot
AQ
Edwards Lifesciences Reports First Quarter Results
BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It
AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)
AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE
AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
BU
Edwards Lifesciences: Q4 Earnings Snapshot
AQ
Edwards Lifesciences Reports Fourth Quarter Results
BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EW Stock
  4. 0REN Stock
  5. News Edwards Lifesciences Corporation
  6. Press Releases